Mary Caffrey

Scientists compared genomes of more than 20,000 people with schizophrenia and 20,000 without the mental disorder to uncover the variants associated with the disease.

The matchstick-size pump has been heralded as a game changer in addressing the biggest problem in diabetes care: medication adherence.

The authors leave open the possibility that current reporting systems are not catching the impact of all medication errors. A different study earlier this year found that medical errors, including those that involve medication, caused so many deaths that the CDC should change its reporting methods to account for them.

The meeting in New Orleans featured surprising clinical findings and some attention-grabbing consumer news.

Earlier this month, 2 members of Congress called for the Justice Department and the Federal Trade Commission to examine whether the major insulin manufacturers are coordinating on prices.

Public health officials scrutinize obesity rates among young children as an indicator of how efforts to combat the epidemic are faring overall.

The report did not break out the number of overdose deaths, but prior information said that 2014 had the most overdose deaths on record.

Studies of the effect of diet soda on diabetes and obesity have produced mixed results.

A study inspired by a patient who could not afford his heart medication shows that there was no pattern to price variability for a common regimen to treat heart failure, which could contribute to poor adherence.

For some time, cardiologists have wondered whether there was anything to be gained by pushing LDL or "bad" cholesterol to very low levels.

A study of a pair of large databases shows a strong link between obesity and heart failure.

The study finds one-quarter of the patients stop taking anticoagulants within 3 months and nearly three-quarters have stopped after 2.25 years.

The results point to the need for more study on the effects of long-duration blood pressure treatment to prevent cognitive decline, especially in the highest risk patients.

The results from a wide-ranging public health effort in Howard County, Maryland, show a decline in sugary beverage consumption nearly on par with early results from Berkeley, California, which passed the nation's first soda tax.

A review of data of patients with cardiomyopathy found that those who had used marijuana were more likely to be younger males with fewer pre-existing cardiovascular risk factors.

A transition statement on healthcare makes no mention of prescription drug prices, despite Trump's strong positions as a candidate. A pharmaceutical executive, former Christie Administration Chief of Staff Rich Bagger, took leave in July to run the Trump transition.

A new wearable medical device helped patients replace a stress response that is lost for those with type 2 diabetes.

Comments on the draft recommendation on obesity screening are being accepted through November 28, 2016.

The ban on insurers using pre-existing conditions to deny coverage is hugely popular with voters in both parties.

Scientific collaboration with Janssen Pharmaceuticals could reveal solutions to block the progression of diseases like Alzheimer's.

Three of the 4 cities to pass taxes on soda are in Northern California, not far from Berkeley, which passed the nation's first soda tax in 2014.

Patients often try, and fail, on medications before settling on one that works for anxiety or depression. A new test can help physicians select the correct medication the first time.

The findings come as epidemiologists have noted rising rates of liver cancer amid falling rates of cancer generally.

A spokesman for The Obesity Society said that lack of payer coverage for obesity may discourage physicians from recording body mass index and making a formal diagnosis.

A healthcare economist explains that not all experiments with new payment models need to succeed, because failure can show the system what not to do.

Audits, consumer education, and help for states were among the recommendations to force better compliance with the 2008 law, which seeks to ensure that coverage for mental health or substance abuse disorders mirrors other benefits in a health plan.

The study identifies a potential drug target to treat diabetes.

The Affordable Care Act called for making it easier for practices to pursue models like collaborative care by allowing physicians to bill for it.

The program has been shown to reduce by 58% the likelihood of progressing to type 2 diabetes. Reimbursement details are still being worked out, but CMS clarified that Medicare patients will not be subject to cost-sharing.

The WalletHub scores examine overall obesity rates, health indicators such as diabetes and cholesterol, and habits such as fruit and vegetable consumption.